Adult infection with hepatitis A despite declining endemicity; in favor of adult vaccination (original) (raw)

Abstract

Seropositivity against hepatitis A was examined among 4806 standing army personnel (4497 males and 309 females) during 1998-1999. Each biannual birth cohort examined showed a decline in seropositivity compared to the previous one. When compared with a study

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (13)

  1. Kark JD, Bar-Shany S. Hepatitis A antibody in Israel Defense Forces recruits. J Med Virol 1980;6:341-5.
  2. Kark JD, Camhy NA, Bar-Shany S. Reduction in hepatitis A antibody prevalence among young adults in Israel. Public Health Rev 1992/3;20:31-40.
  3. Gdalevich M, Grotti I, Mandel Y, Mimouni D, Shemer J, Ashkenazi I. Hepatitis A antibody prevalence among young adults in Israel: the decline continues. Epidemiol Infect 1998;121:477-9.
  4. Green MS, Tsur S, Slepon R. Sociodemographic factors and the declining prevalence of anti-hepatitis A antibodies in young adults in Israel: implications for the new hepatitis A vaccines. Int J Epidemiol 1992;21:136-41.
  5. Kark JD, Bar-Shany S, Shor S, Merlinski L, Nili E. Serological hepatitis A virus infections and ratio of clinical to serological infections in a controlled trial of pre-exposure prophylaxis with immune serum globulin. J Epidemiol Community Health 1985;39: 117-22.
  6. Kilpatrick ME, Escamilla J. Hepatitis in Peru: the role of children. Am J Epidemiol 1986;124:11113.
  7. Sarov B. Seroepidemiology and transmission of hepatitis A virus among young children in the Negev, Israel. PhD dissertation, Ben-Gurion University of the Negev, Beersheba, Israel, 1987.
  8. Gdalevich M, Gillis D, Mimouni D, Grotto I, Shpilberg O. Trends in epidemiology of hepatitis in the Israel Defense Forces. Harefuah 2000;138:755-7.
  9. Swartz TA, Levin J, Ben Porat E. Epidemiology of hepatitis A in Israel. Monogr Virol 1984;15:53-8.
  10. Ambrosch F, Kunz C, Frisch-Niggemeyer W, Wiedermann G, Wustinger E. Hepatitis A: antikorperkonversion unter dem schutz von ␥-globulin (hepatitis A: antibody conversion under ␥-globulin). Wien Klin Wochenschr 1980;92:156-7.
  11. Fujiyama S, Odoh K, Kuramoto I, Mizuno K, Tsurusaki R, Sato T. Current seroepidemiological status of hepatitis A with a comparison of antibody titers after infection and vaccination. J Hepatol 1994;21:641-5.
  12. Anis E, Leventhal A, Roitman M, Slater PE. Introduction of routine hepatitis A immunization in Israel: the first in the world. Harefuah 2000;138:177-80.
  13. Green MS, Block C. Apparent effect of immune serum globulin prophylaxis in the military on viral hepatitis incidence in the civilian population in Israel. J Epidemiol Community Health 1989;43: 87-90.